The federal government has ramped up efforts to stamp out fraud, waste, and abuse. Increasingly, DME companies find themselves under the magnifying glass. We discuss how to prepare your DME business and remain compliant.
The proliferation of mobile apps in healthcare has prompted the FDA to clarify its enforcement priorities. Does your medical app fall into one of the regulated categories?
Referral fees may sound like a smart strategy to get more physical therapy clients, but the federal government constrains such activities. Learn why exchanging money or gifts for referrals can be problematic.
Most medical practices treat the decision to require employment contracts for new physicians as almost automatic. But should you consider such agreements for your other staff? We help you evaluate.
Job loss and other factors are driving an insurance coverage gap that may affect your practice. How can you prepare for the coming storm?
Learn about the state and federal efforts to allow you to provide life-saving aid without fear of civil or criminal liability during the COVID-19 pandemic.
During the COVID-19 pandemic, rumors about HIPAA abound. If you’re confused, we offer some clarity on the most common misunderstandings.
We answer some of the most frequently asked questions from clients who are interested in forming a corporate entity but need additional information and clarification.
Have you been issuing ABNs, but are unsure whether it’s appropriate? Are you uncertain if ABNs are relevant to you as a provider not enrolled in Medicare? Keep reading to learn when to use ABNs.
The FDA recommends that physicians and other clinicians consider prescribing naloxone for patients at increased risk of opioid overdose.
